会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS
    • 新型羟基-6-羟基噻嗪类及其作为PDE4抑制剂的用途
    • WO2005085225A1
    • 2005-09-15
    • PCT/EP2005/050931
    • 2005-03-02
    • ALTANA PHARMA AGKAUTZ, Ulrich
    • KAUTZ, UlrichSCHMIDT, BeateFLOCKERZI, DieterHATZELMANN, ArminZITT, ChristofBARSIG, JohannesMARX, DegenhardKLEY, Hans-Peter
    • C07D401/04
    • A61K31/473A61K31/4985A61K31/501A61K31/506A61K31/5377C07D401/04C07D401/14C07D405/04C07D413/04C07D417/04C07D417/14C07D471/04
    • Compounds of formula (I), in which R1 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy, 2,2-difluoroethoxy, or completely or predominantly fluorine-substituted 1-4C-alkoxy, R2 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy, 2,2-difluoroethoxy, or completely or predominantly fluorine-substituted 1-4C-alkoxy, or in which R1 and R2 together are a 1-2C-alkylenedioxy group, R3 is hydrogen or 1-4C-alkyl, R31 is hydrogen or 1-4C-alkyl, either, in a first embodiment (embodiment a) according to the present invention, R4 is -O-R41, in which R41 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy-1-4C-alkyl, hydroxy-2-4C-alkyl, 1-7C-alkylcarbonyl, or completely or predominantly fluorine-substituted 1-4C-alkyl, and R5 is hydrogen or 1-4C-alkyl, or, in a second embodiment (embodiment b) according to the present invention, R4 is hydrogen or 1-4C-alkyl, and R5 is -O-R51, in which R51 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy-1-4C-alkyl, hydroxy-2-4C-alkyl, 1-7C-alkylcarbonyl, or completely or predominantly fluorine-substituted 1-4C-alkyl, Har is optionally substituted by R6 and/or R7 and/or R8, and is a 5- to 10-membered monocylic or fused bicyclic unsaturated or partially saturated heteroaryl radical comprising 1 to 4 heteroatoms selected independently from the group consisting of oxygen, nitrogen and sulfur, are novel effective PDE4 inhibitors.
    • 式(I)化合物,其中R 1是羟基,1-4C-烷氧基,3-7C-环烷氧基,3-7C-环烷基甲氧基,2,2-二氟乙氧基或完全或主要是氟取代的1-4C-烷氧基, R2是羟基,1-4C-烷氧基,3-7C-环烷氧基,3-7C-环烷基甲氧基,2,2-二氟乙氧基或完全或主要是氟取代的1-4C-烷氧基,或其中R1和R2一起是 1-2C-亚烷基二氧基,R3是氢或1-4C-烷基,R31是氢或1-4C-烷基,在根据本发明的第一个实施方案(实施方案a)中,R 4是-O-R 41, 其中R41是氢,1-4C-烷基,1-4C-烷氧基-1-4C-烷基,羟基-24C-烷基,1-7C-烷基羰基,或完全或主要是氟取代的1-4C-烷基 或者R5为氢或1-4C-烷基,或在本发明的第二实施方案(实施方案b)中,R 4为氢或1-4C-烷基,R 5为-O-R 51,其中R 51为 氢,1-4C-烷基,1-4C-烷氧基-1-4C-烷基,羟基-24C-烷基,1-7C-烷基羰基或com 完全或主要是氟取代的1-4C-烷基,Har任选被R 6和/或R 7和/或R 8取代,并且是5至10元单环或稠合双环不饱和或部分饱和的杂芳基,其包含1至4个 独立选自氧,氮和硫的杂原子是新的有效的PDE4抑制剂。
    • 3. 发明申请
    • NOVEL AMIDO-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS
    • 新型氨基取代的羟基-6-苯基噻吩并作为PDE4抑制剂使用
    • WO2005087745A1
    • 2005-09-22
    • PCT/EP2005/051054
    • 2005-03-09
    • ALTANA PHARMA AGKAUTZ, Ulrich
    • KAUTZ, UlrichSCHMIDT, BeateFLOCKERZI, DieterHATZELMANN, ArminZITT, ChristofBARSIG, JohannesMARX, DegenhardKLEY, Hans-Peter
    • C07D221/12
    • C07D221/12C07D401/12C07D471/04
    • Compounds of formula (I) in which R1 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3-7C-cycloalkylmethoxy, 2,2-difluoroethoxy, or com­ pletely or predominantly fluorine-substituted 1-4C-alkoxy, R2 is hydroxyl, 1-4C-alkoxy, 3-7C-cycloalkoxy, 3 . 7C-cycloalkylmethoxy, 2,2-difluoroethoxy, or com­ pletely or predominantly fluorine-substituted 1-4C-alkoxy, or in which R1 and R2 together are a 1-2C-alkylenedioxy group, R3 is hydrogen or 1-4C-alkyl, R31 is hydrogen or 1-4C-alkyl, either, in a first embodiment (embodiment a) according to the present invention, R4 is -0-R41, in which R41 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy-1-4C-alkyl, hydroxy-2-4C-alkyl, 1-7C-alkylcarbonyl, or com­ pletely or predominantly fluorine-substituted 1-4C-alkyl. and R5 is hydrogen or 1-4C-alkyl, or, in a second embodiment (embodiment b) according to the present invention, R4 is hydrogen or 1-4C-alkyl, and R5 is -0-R51, in which R51 is hydrogen, 1-4C-alkyl, 1-4C-alkoxy-1-4C-alkyl, hydroxy-2-4C-alkyl, 1-7C-alkylcarbonyt, or com­ pletely or predominantly fluorine-substituted 1-4C-alkyl, R6 is hydrogen, halogen, 1-4C-alkyl or 1-4C-alkoxy, either, in a first aspect (aspect 1) according to the present invention, R7 is -N(R8)R9, or, in a second aspect (aspect 2) according to the present invention, R7 is -NH-N(R18)R19, are novel effective PDE4 inhibitors.
    • 其中R1是羟基,1-4C-烷氧基,3-7C-环烷氧基,3-7C-环烷基甲氧基,2,2-二氟乙氧基或完全或主要是氟取代的1-4C-烷氧基的式(Ⅰ)化合物, R2是羟基,1-4C-烷氧基,3-7C-环烷氧基,3,7-环烷基甲氧基,2,2-二氟乙氧基或完全或主要是氟取代的1-4C-烷氧基,或其中R1和R2 在根据本发明的第一实施方案(实施方案a)中,R 1是亚烷基二氧基,R 3是氢或1-4C-烷基,R 31是氢或1-4C-烷基,R 4是-O -R41,其中R41是氢,1-4C-烷基,1-4C-烷氧基-1- 1-4C-烷基,羟基-24C-烷基,1-7C-烷基羰基,或完全或主要是氟取代的1 1-4C-烷基。 或者R5是氢或1-4C-烷基,或者在根据本发明的第二个实施方案(实施方案b)中,R4是氢或1-4C-烷基,R5是-O-R51,其中R51是氢 1-4C-烷基,1-4C-烷氧基-14C-烷基,羟基-24C-烷基,1-7C-烷基羰基,或完全或主要是氟取代的1-4C-烷基,R6是氢 ,卤素,1-4C-烷基或1-4C-烷氧基,在根据本发明的第一方面(方面1)中,R7是-N(R8)R9,或在第二方面(方面2)中, 根据本发明,R7是-NH-N(R18)R19,是新型有效的PDE4抑制剂。
    • 10. 发明申请
    • NOVEL HETEROCYCLYL-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS
    • 新型环己基取代的羟基-6-苯基噻吩并作为PDE4抑制剂使用
    • WO2005090311A1
    • 2005-09-29
    • PCT/EP2005/050946
    • 2005-03-03
    • ALTANA PHARMA AGKAUTZ, Ulrich
    • KAUTZ, UlrichSCHMIDT, BeateFLOCKERZI, DieterHATZELMANN, ArminZITT, ChristofBARSIG, JohannesMARX, DegenhardKLEY, Hans-Peter
    • C07D221/12
    • C07D221/12C07D401/10C07D413/10C07D417/10
    • Compounds of formula (I) in which R1 is hydroxyl, 1-4C-alkoxy, 3-7C-cydoalkoxy, 3-7C-cydoalkylmethoxy, 2,2-difluoroethoxy, or completely or predominantly fluorine-substituted 1-4C-alkoxy, R2 is hydroxyl, 1-4C-aikoxy, 3-7C-cydoalkoxy, 3-7C-cydoalkylmethoxy, 2,2-difluoroethoxy, or completely or predominantly fluorine-substituted 1-4C-alkoxy, or in which R1 and R2 together are a 1-2C-alkylenedioxy group, R3 is hydrogen or 1-4C-alkyl, R31 is hydrogen or 1-4C-alkyl, either, in a first embodiment (embodiment a) according to the present invention, R4 is -O-R41, in which R41 is hydrogen, 1-4C-aikyl,1-4C-alkoxy-1-4C-alkyl, hydroxy-2-C-alkyl, 1-7C-alkylcarbonyl, or completely or predominantly fluorine-substituted 1-4C-alkyl, and R5 is hydrogen or 1-4C-alkyl, or, in a second embodiment (embodiment b) according to the present invention, R4 Is hydrogen or 1-4C-alkyl, and R5 is -O-R51, in which R51 Is hydrogen, 1-4C-alkyl, 1-4C-alkoxy-1-4C-alkyl, hydroxy-2-4C-alkyl. 1-7C-alkylcarbonyl, or completely or predominantly fluorine-substituted 1-4C-alkyl, R6 is hydrogen, halogen, 1-4C-alkyl or 1.4C-alkoxy, R7 is Het1, Het2, Hart, Het3 or Har2, In which.
    • 其中R1是羟基,1-4C-烷氧基,3-7C-环烷氧基,3-7C-环烷基甲氧基,2,2-二氟乙氧基或完全或主要是氟取代的1-4C-烷氧基的式(I)化合物,R2 是羟基,1-4C-烷氧基,3-7C-环烷氧基,3-7C-环烷基甲氧基,2,2-二氟乙氧基或完全或主要是氟取代的1-4C-烷氧基,或其中R1和R2一起为1 -2C-亚烷基二氧基,R3是氢或1-4C-烷基,R31是氢或1-4C-烷基,在根据本发明的第一个实施方案(实施方案a)中,R 4是-O-R 41,在 其中R41是氢,1-4C-烷基,1-4C-烷氧基-1-4C-烷基,羟基-2- C-烷基,1-7C-烷基羰基,或完全或主要是氟取代的1-4C-烷基, 或者R5是氢或1-4C-烷基,或者在根据本发明的第二个实施方案(实施方案b)中,R4是氢或1-4C-烷基,R5是-O-R51,其中R51是氢 1-4C-烷基,1-4C-烷氧基-14C-烷基,羟基-24C-烷基。 1-7C-烷基羰基,或完全或主要是氟取代的1-4C-烷基,R6是氢,卤素,1-4C-烷基或1-4C-烷氧基,R7是Het1,Het2,Hart,Het3或Har2,其中 。